2017 ISAKOS Biennial Congress ePoster #2256
A Preliminary Report Of Outcomes In Arthroscopic Rotator Repair With Extracellular Matrix Augmentation
Mohamed A. Imam, MD, MSc, DSportMed, ELD (Oxon), PhD, FRCS, London UNITED KINGDOM
Paolo Consigliere, MD, Reading, Berkshire UNITED KINGDOM
Ioannis Polyzois, MD, Chertsey UNITED KINGDOM
Tanya Sarkhel , FRCS Orth, Chertsey UNITED KINGDOM
Rohit R Gupta, BSc(Hons) MBBS FRCS(Eng) FRCS(Tr&Orth), Chertsey, Surrey UNITED KINGDOM
Ofer Levy, MD, MCh(Orth), FRCS, Reading, Berkshire UNITED KINGDOM
Ali Narvani, FRCS, Reading UNITED KINGDOM
Ashford and St Peters Hospital, Chertsey, UNITED KINGDOM
FDA Status Cleared
Summary
A preliminary report of outcomes in arthroscopic rotator repair with extracellular matrix augmentation
ePosters will be available shortly before Congress
Abstract
Purpose
To investigate the outcome of arthroscopic rotator cuff repair of large and massive rotator cuff repairs performed with extracellular matrix augmentation.
Methods
Fourteen consecutive patients undergoing arthroscopic rotator cuff repair with extracellular matrix augment for large and massive tears were prospectively enrolled into this single surgeon study. The patients were scored preoperatively with Constant and Oxford scores and again at 3 months, 6months and 1year post surgery. Visual analogue scores were also recorded. All repairs were performed arthroscopically with a double row technique augmented with extracellular matrix. Patients were rehabilitated with standardised protocol. Minimum follow up was 6 months.
Results
Mean Constant score improved from 54 (SD=2.3) pre-operatively to 75 (SD=12) at final follow up (p<0.05). Mean Oxford score also increased from 32.6 (SD=7.8) pre-operatively to 50.7 (SD=6.7) at the final follow up (p<0.05). The visual analogue scale (VAS) improved from 6.2 out of 10 (SD=1.5) preoperatively to 0.4 (SD=0.8) at final follow up (p<0.05).
Conclusions
Our results demonstrate significant improvements in both function and pain following arthroscopic rotator cuff repair with extracellular matrix augmentation at minimum of 6 months follow up. These findings highlight the need for large scale randomised controlled trials on role of arthroscopic rotator cuff repair of large and massive tears with augmentation.